Mechanical Low-Pass Filtering of Cells for Detection of Circulating Tumor Cells in Whole Blood10.1021/acs.analchem.9b03939

• Published in: Analytical chemistry (Washington) Vol. 92; no. 3; p. 2483
• Main Authors: Suzuki, Taiki, Kaji, Noritada, Yasaki, Hirotoshi, Yasui, Takao, Baba, Yoshinobu
• Format: Journal Article
• Language: English
• Published: Washington American Chemical Society 04.02.2020
• Subjects: Analytical chemistry; Antibodies; Antigens; Blood; Cell adhesion; Cell adhesion & migration; Cell adhesion molecules; Cell surface; Chemical compounds; Chemistry; Constrictions; Diagnostic systems; Dilution; Epithelial cells; Fluorescence; Fluorophores; Invasiveness; Low pass filters; Lymphocytes; Lymphocytes T; Mechanical analysis; Microfluidic devices; Microfluidics; Pretreatment; Tumor cells; Tumors
• ISSN: 0003-2700; 1520-6882
• DOI: 10.1021/acs.analchem.9b03939

The detection of circulating tumor cells (CTCs) from liquid biopsies using microfluidic devices is attracting a considerable amount of attention as a new, less-invasive cancer diagnostic and prognostic method. One of the drawbacks of the existing antibody-based detection systems is the false negatives for epithelial cell adhesion molecule detection of CTCs. Here we report a mechanical low-pass filtering technique based on a microfluidic constriction and electrical current sensing system for the novel CTC detection in whole blood without any specific antigen–antibody interaction or biochemical modification of the cell surface. The mechanical response of model cells of CTCs, such as HeLa, A549, and MDA-MB-231 cells, clearly demonstrated different behaviors from that of Jurkat cells, a human T-lymphocyte cell line, when they passed through the 6-μm wide constriction channel. A 6-μm wide constriction channel was determined as the optimum size to identify CTCs in whole blood with an accuracy greater than 95% in tens of milliseconds. The mechanical filtering of cells at a single cell level was achieved from whole blood without any pretreatment (e.g., dilution of lysing) and prelabeling (e.g., fluorophores or antibodies).